X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs SUVEN LIFE - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. SUVEN LIFE WOCKHARDT LTD./
SUVEN LIFE
 
P/E (TTM) x -19.1 17.2 - View Chart
P/BV x 2.0 3.8 53.8% View Chart
Dividend Yield % 0.0 0.6 0.3%  

Financials

 WOCKHARDT LTD.   SUVEN LIFE
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-18
SUVEN LIFE
Mar-18
WOCKHARDT LTD./
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs1,012251 403.5%   
Low Rs532155 342.9%   
Sales per share (Unadj.) Rs355.949.1 724.4%  
Earnings per share (Unadj.) Rs-60.39.7 -620.3%  
Cash flow per share (Unadj.) Rs-46.811.4 -410.5%  
Dividends per share (Unadj.) Rs0.011.50 0.7%  
Dividend yield (eoy) %00.7 0.2%  
Book value per share (Unadj.) Rs257.860.3 427.6%  
Shares outstanding (eoy) m110.63127.28 86.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.24.1 52.5%   
Avg P/E ratio x-12.820.9 -61.3%  
P/CF ratio (eoy) x-16.517.8 -92.7%  
Price / Book Value ratio x3.03.4 89.0%  
Dividend payout %015.4 -0.1%   
Avg Mkt Cap Rs m85,37925,825 330.6%   
No. of employees `0006.31.1 583.4%   
Total wages/salary Rs m9,371613 1,529.4%   
Avg. sales/employee Rs Th6,295.05,832.6 107.9%   
Avg. wages/employee Rs Th1,498.3571.5 262.2%   
Avg. net profit/employee Rs Th-1,066.31,153.8 -92.4%   
INCOME DATA
Net Sales Rs m39,3696,253 629.6%  
Other income Rs m1,202233 516.7%   
Total revenues Rs m40,5716,485 625.6%   
Gross profit Rs m181,982 0.9%  
Depreciation Rs m1,495213 701.7%   
Interest Rs m2,55546 5,518.1%   
Profit before tax Rs m-2,8301,955 -144.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m257718 35.8%   
Profit after tax Rs m-6,6691,237 -539.2%  
Gross profit margin %031.7 0.1%  
Effective tax rate %-9.136.7 -24.7%   
Net profit margin %-16.919.8 -85.6%  
BALANCE SHEET DATA
Current assets Rs m33,7965,622 601.1%   
Current liabilities Rs m26,9171,168 2,305.3%   
Net working cap to sales %17.571.2 24.5%  
Current ratio x1.34.8 26.1%  
Inventory Days Days7981 97.4%  
Debtors Days Days8936 248.4%  
Net fixed assets Rs m39,6643,325 1,193.0%   
Share capital Rs m553127 434.6%   
"Free" reserves Rs m27,9687,547 370.6%   
Net worth Rs m28,5227,674 371.7%   
Long term debt Rs m21,73114 156,338.8%   
Total assets Rs m81,6209,135 893.5%  
Interest coverage x-0.143.2 -0.2%   
Debt to equity ratio x0.80 42,065.1%  
Sales to assets ratio x0.50.7 70.5%   
Return on assets %-5.014.0 -35.9%  
Return on equity %-23.416.1 -145.1%  
Return on capital %-7.726.0 -29.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,8075,066 193.6%   
Fx outflow Rs m1,7892,001 89.4%   
Net fx Rs m8,0193,065 261.6%   
CASH FLOW
From Operations Rs m684699 97.9%  
From Investments Rs m6,302-6 -103,318.0%  
From Financial Activity Rs m-7,695-577 1,333.6%  
Net Cashflow Rs m-664116 -570.9%  

Share Holding

Indian Promoters % 74.5 63.4 117.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 0.0 -  
FIIs % 7.7 0.0 -  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 36.5 42.2%  
Shareholders   67,757 37,287 181.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   ALEMBIC PHARMA  STRIDES PHARMA SCIENCE  TTK HEALTHCARE  JUBILANT LIFE SCIENCES  DISHMAN PHARMA  

Compare WOCKHARDT LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Macroeconomic Cues Guide the Markets This Week(Podcast)

Global markets remained in pressure this week. Pound fell sharply as risk of chaotic Brexit rose.

Related Views on News

WOCKHARDT LTD. Announces Quarterly Results (2QFY19); Net Profit Down 158.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, WOCKHARDT LTD. has posted a net profit of Rs 228 m (down 158.2% YoY). Sales on the other hand came in at Rs 11 bn (up 10.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Nov 16, 2018 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 5-YR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS